|
Healthcare
BIO’s comments in response to the Arizona Health Care Cost Containment System (AHCCCS) Administration’s Notice of Request for Proposal (RFP) on the Specialty Pharmacy Drugs and Services Program (November 10, 2009)
Read the letter (110 KB PDF)
Letter to Congress from 10 Governors Reflecting Their Support of Biosimilars (September 29, 2009)
Read the letter (346 KB PDF)
BIO’s final comments as submitted to HHSC Regarding Texas Rider 48 (September 18, 2009)
Read the comments (807 KB PDF)
Letter to Governor Schwarzenegger requesting veto of California Senate Bill 486 (September 16, 2009)
Read the comments (1.24 MB PDF)
Georgia Department of Community Health’s Re-Issued Notice of Proposed Changes to the Physician’s Injectable Drug List (PIDL) for Medicaid (July 30, 2009)
Read the comments (640 KB PDF)
Comments in Response to Notice of Proposed Rulemaking: Department of Health and Human Services, 10-144, Chapter 275 - Reporting Requirements for Pharmaceutical Manufacturers and Labelers, and Office of the Attorney General, 26-239, Chapter 111 - Reporting Requirements for Pharmaceutical Manufacturers and Labelers (July 13, 2009)
Read the comments (278 KB PDF)
BIO’s testimony opposing Massachusetts House Bill 109, Senate Bill 17, and Senate Bill 19 (March 26, 2009)
Read the comments (757 KB PDF)
BIO’s testimony to the Maryland Health and Government Operations Committee opposing House Bill 1155 the Prescription Confidentiality Act (March 12, 2009)
Read the comments (975 KB PDF)
BIO’s testimony opposing Connecticut Senate Bill 1050: An Act Concerning the Establishment of an Academic Detailing Program (March 2, 2009)
Read the comments (100 KB PDF)
BIO’s testimony opposing Connecticut Senate Bill 1049: An Act Prohibiting Certain Gifts from Pharmaceutical and Medical Device Companies to Health Care Providers (March 2, 2009)
Read the comments (128 KB PDF)
BIO’s testimony opposing Connecticut Senate Bill 1046: An Act Concerning Restricted Access to Prescription Drug Information (March 2, 2009)
Read the comments (148 KB PDF)
BIO’s testimony to House Health and Operations Committee regarding MD House Bill 574 (February 26, 2009)
BIO’s testimony on Maryland House Bill 574: Prescription Drugs - Evidence Based Prescriber Education and Outreach Program
Read the comments (200 KB PDF)
Maryland Senate Bill 417 - The Prescription Confidentiality Act (February 20, 2009)
Letter to Chair of the Maryland Senate Finance Committee
Read the letter (620 KB PDF)
BIO’s Testimony to the Maryland Senate Finance Committee
Read the letter (915 KB PDF)
BIO’s letter to Montana House Human Services Committee opposing House Bill HB394 (February 9, 2009 )
BIO’s Statement of Opposition to House Bill HB394
Read the comments (83 KB PDF)
Frequently Asked Questions: Licensure and Regulation of Pharmaceutical Detailers document (November 20, 2008)
BIO’s comments on the District of Columbia’s draft SafeRx
Read the comments (2.63 MB PDF)
BIO's letter regarding Chapter 305 of the Acts of 2008, An Act To Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care (November 6, 2008)
Letter to Massachusetts Secretary JudyAnn Bigby, MD Executive Office of Health and Human Services and Secretary Daniel O’Connell, Executive Office of Housing and Workforce Development
Read the letter (197 KB PDF)
Wholesale Distribution Senate Bill 759 Workgroup: Target Date for Implementation of Electronic Track and Trace Pedigree Technology for Maryland (October 24, 2008)
BIO letter to the Maryland Board of Pharmacy
Read the letter (110 KB PDF)
Questions for the District of Columbia Board of Pharmacy for the drafting of SafeRx Frequently Asked Questions Document
Read the questions
Letter to Commissioner Bart L. Graham, Commissioner, Georgia Department of Revenue (September 15, 2008)
BIO Letter to Commissioner Bart L. Graham of Georgia regarding proposed further changes to adopted Rule 560-12-1-.14, entitled "Withdrawals from Inventory."
Read the letter (58 KB PDF)
Letter to Commissioner Bart L. Graham, Commissioner, Georgia Department of Revenue (August 25, 2008)
BIO Letter to Commissioner Bart L. Graham of Georgia regarding the proposed amendment of Rule 560-12-1.14
Read the letter (110 KB PDF)
Letter to Governor Deval Patrick (August 7, 2008)
BIO letter to Governor Deval Patrick of Massachusetts regarding concerns about Senate Bill 2863
Read the letter (95 KB PDF)
Letter to Governor Acevedo-Vila (July 30, 2008)
BIO letter to the Governor Anibal Acevedo-Vila requesting the veto of Puerto Rico House of Representatives Bill Number 506
Read the letter (85 KB PDF)
BIO Final Comments to DC on Licensure of Pharmaceutical Detailers (July 24, 2008)
Read the comments (264 KB PDF)
Letter Regarding Massachusetts Universal Coverage Mandate (March 15, 2007)
BIO letter to the Commonwealth Health Insurance Connector Authority regarding the inclusion of prescription drugs for Minimum Creditable Coverage (MCC) under the Commonwealth Choice program.
Read the letter (104 KB PDF)
State Legislative Best Practices in Support of Bioscience Industry Development
This document provides examples of state efforts to invest in early stage research and research facilities, to encourage capital investment; to develop trained workforces, and to help create, grow, and retain bioscience companies. It has been developed to explain the rationale behind current legislative efforts as well as serve as a practical reference guide to the specific legislation put in place in the states.
View the report.
Food & Agriculture
Testimony opposing Hawaii House Bill 1048 (February 1, 2007)
BIO testimony opposing Hawaii House Bill 1048 which proposes a ban on all plantings of plant-made pharmaceutical, including in the laboratory setting.
Read the testimony. (43 KB PDF)
Bioethics
Letter to Wisconsin Governor Jim Doyle
Letter to the Honorable Jim Doyle, Governor of Wisconsin, regarding Assembly Bill 499 (October 3, 2005).
Read the letter (25 KB PDF)
| 
